R&D expense · 2011–2025
Veracyte R&D expense
$70.8M+2.2% · FY2025
Veracyte (VCYT) reported $70.8M in R&D expense for fiscal 2025, +2.2% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $70.8M | +2.2% | Open → |
| FY20242024-12-31 | $69.3M | +20.9% | Open → |
| FY20232023-12-31 | $57.3M | +41.1% | Open → |
| FY20222022-12-31 | $40.6M | +36.1% | Open → |
| FY20212021-12-31 | $29.8M | +73.5% | Open → |
| FY20202020-12-31 | $17.2M | +15.8% | Open → |
| FY20192019-12-31 | $14.9M | +0.2% | Open → |
| FY20182018-12-31 | $14.8M | +6.8% | Open → |
| FY20172017-12-31 | $13.9M | −9.4% | Open → |
| FY20162016-12-31 | $15.3M | +19.8% | Open → |
| FY20152015-12-31 | $12.8M | +30.5% | Open → |
| FY20142014-12-31 | $9.8M | +25.5% | Open → |
| FY20132013-12-31 | $7.8M | +18.2% | Open → |
| FY20122012-12-31 | $6.6M | −1.1% | Open → |
| FY20112011-12-31 | $6.7M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +18.4%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Veracyte R&D expense |url=https://companiesranked.com/en/company/veracyte/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Veracyte R&D expense. CompaniesRanked. https://companiesranked.com/en/company/veracyte/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-veracyte-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Veracyte R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/veracyte/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001384101-26-000010 · February 26, 2026
{{cite web |title=Veracyte R&D expense — 10-K (0001384101-26-000010) |url=https://www.sec.gov/Archives/edgar/data/1384101/000138410126000010/vcyt-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.